APA (7th ed.) Citation

JE, O., DR, R., BA, S., MS, I., P, T., H, Y., . . . LM, W. (2020). Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatric blood & cancer, 67(7), e28370. https://doi.org/10.1002/pbc.28370

Chicago Style (17th ed.) Citation

JE, Oesterheld, et al. "Phase II Trial of Gemcitabine and Nab-paclitaxel in Patients with Recurrent Ewing Sarcoma: A Report from the National Pediatric Cancer Foundation." Pediatric Blood & Cancer 67, no. 7 (2020): e28370. https://doi.org/10.1002/pbc.28370.

MLA (9th ed.) Citation

JE, Oesterheld, et al. "Phase II Trial of Gemcitabine and Nab-paclitaxel in Patients with Recurrent Ewing Sarcoma: A Report from the National Pediatric Cancer Foundation." Pediatric Blood & Cancer, vol. 67, no. 7, 2020, p. e28370, https://doi.org/10.1002/pbc.28370.